New health risks, rapidly evolving and increasingly complex drug markets - this is the warning issued on Tuesday by the European Union Drugs Agency.
Its annual report, based on data from 27 EU member states as well as Turkey and Norway, highlights concerns not only about the availability of substances but also their growing variety, unpredictability and potency.
